Showing results (61-70 of 465) with videos related to
Sort By:
Pageof 47
Expert Review of Neurotherapeutics|June 10, 2011
Pathological gambling in Parkinson's disease: disease related or drug related?Daniela Calandrella, Angelo AntoniniExpert Opinion on Drug Metabolism & Toxicology|September 7, 2011
Pharmacokinetic evaluation of pramipexoleAngelo Antonini, Daniela CalandrellaExpert Review of Neurotherapeutics|June 6, 2009
Apomorphine and levodopa infusion therapies for advanced Parkinson's disease: selection criteria and patient managementAngelo Antonini, Eduardo TolosaSleep Medicine|March 23, 2004
PET and SPECT functional imaging in Parkinson's diseaseAngelo Antonini, Roberta DeNotarisExpert Review of Neurotherapeutics|January 17, 2014
Novel levodopa formulations in the treatment of Parkinson's diseaseManuela Pilleri, Angelo AntoniniExpert Opinion on Drug Safety|December 9, 2014
Therapeutic strategies to prevent and manage dyskinesias in Parkinson's diseaseManuela Pilleri, Angelo AntoniniJournal of Neural Transmission (Vienna, Austria : 1996)|July 15, 2018
Apomorphine and levodopa infusion for motor fluctuations and dyskinesia in advanced Parkinson diseaseAngelo Antonini, Bianca NituMovement Disorders : Official Journal of the Movement Disorder Society|February 25, 2020
Automated MRI Classification in Progressive Supranuclear Palsy: A Large International Cohort StudySalvatore Nigro, Angelo Antonini, David E Vaillancourt, et al.Movement Disorders : Official Journal of the Movement Disorder Society|March 20, 2025
Conversion between NMSS and MDS-NMS in Parkinson's DiseaseMichela Garon, José-Manuel Rojo-Albuin, K Ray Chaudhuri, et al.Expert Review of Neurotherapeutics|December 3, 2015
The efficacy of oral adenosine A(2A) antagonist istradefylline for the treatment of moderate to severe Parkinson's diseaseRuxandra Julia Vorovenci, Angelo AntoniniPageof 47